1990
DOI: 10.1111/j.1751-0813.1990.tb07745.x
|View full text |Cite
|
Sign up to set email alerts
|

Safety of temperature sensitive mutant Mycoplasma gallisepticum vaccine

Abstract: A temperature sensitive (ts) vaccine strain designated ts-11 was selected after exposure of a low passage culture of the immunogenic Australian field isolate (strain 80083) of Mycoplasma gallisepticum to 100 mg/ml of N-methyl-N-nitro-N-nitrosoguanidine. Viable counts (assayed as colour changing units (CCU)/25 microliters) of a thawed stock culture of ts-11 were typically log10 3 to log10 5 higher when incubated at 33 degrees C (the permissive temperature) than duplicate viable counts incubated at 39.5 degrees … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
39
0

Year Published

1994
1994
2020
2020

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 85 publications
(43 citation statements)
references
References 23 publications
4
39
0
Order By: Relevance
“…It has been established that the ts-11 strain of M. gallisepticum does not colonize the air sacs (Whithear et al, 1990b), so isolation from the air sacs and production of air sac lesions were not expected in unchallenged birds. There were no visible air sac lesions in birds vaccinated with GapA + M. gallisepticum ts-11 or Vaxsafe M. gallisepticum ts-11 at 3 or 5 weeks after inoculation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been established that the ts-11 strain of M. gallisepticum does not colonize the air sacs (Whithear et al, 1990b), so isolation from the air sacs and production of air sac lesions were not expected in unchallenged birds. There were no visible air sac lesions in birds vaccinated with GapA + M. gallisepticum ts-11 or Vaxsafe M. gallisepticum ts-11 at 3 or 5 weeks after inoculation.…”
Section: Discussionmentioning
confidence: 99%
“…The ts-11 strain was selected for its ability to multiply in the upper respiratory tract to an extent sufficient to stimulate long-term protective immunity, but not at core body temperature (Whithear et al, 1990b). In this experiment, Vaxsafe M. gallisepticum ts-11 was reisolated from the tracheas of 4/24 birds (groups 5 and 8) in broth, whereas GapA + M. gallisepticum ts-11 was reisolated from 11/26 birds (groups 6 and 9).…”
Section: Discussionmentioning
confidence: 99%
“…The droplet size delivered by this apparatus has been determined previously as between 1 and 10 μm, with the majority of particles <5 μm at an air flow of 15 l/min (Whithear et al, 1996). Aerosols of M. gallisepticum delivered to chickens using this method have induced lesions consistently in the air sacs and the trachea, indicating that there is infection of the upper and lower respiratory tract (Whithear et al, 1990(Whithear et al, , 1996Gaunson et al, 2000Gaunson et al, , 2006. The strain comparison study described here was carried out in order to identify the more appropriate strain for the infection model.…”
Section: Discussionmentioning
confidence: 99%
“…To demonstrate the safety and efficacy of any vaccine candidate, a reproducible infection model is needed, such as the aerosol exposure method developed in our laboratory previously to test vaccine safety and efficacy in chickens using the M. gallisepticum Ap3AS wild-type strain (Whithear et al, 1990(Whithear et al, , 1996. Such a model has not been developed for turkeys.…”
Section: Introductionmentioning
confidence: 99%
“…The strain was selected after exposure passage of an immunogenic Australian field isolate (strain 80083) of MG to N-methyl-nitro-N-nitrosoguanidine (22). This strain was found to be poorly transmitted from vaccinated to unvaccinated birds and showed little or no virulence for chickens and turkeys (21).…”
Section: Introductionmentioning
confidence: 99%